The growing need for more rapid results led to the development of the called Rapid Microbiological Methods (RMM). Some RMM, however, are considered rapid solely when compared to the culture-based methods. RMM result delivery strongly depends on the application and objective, varying from real-time to results usually delivered in up to 48 hours. Most industries soon embraced and helped developing RMM. Pharmaceutical industry, however, for regulatory reasons and deployment issues was not so eager in implementing RMM in their manufacturing processes and product control.

The report analyses the global rapid microbiology testing industry based on method, product, application, end user and geography. Various method studied in the report are growth-based rapid microbiology testing, cellular component-based rapid microbiology testing, nucleic acid-based rapid microbiology testing, viability-based rapid microbiology testing & other rapid microbiology testing methods. The products of the industry are classified into instruments, reagents & kits & consumables. Furthermore, several applications of the industry are segmented into clinical disease diagnosis, food & beverage testing, pharmaceutical & biological drug testing, environmental testing, cosmetics & personal care products testing and research applications and other applications. The end users of rapid microbiology testing industry are diagnostic laboratories & hospitals, food & beverage companies, pharmaceutical & biotechnology companies, contract research organizations, and other end users. The global rapid microbiology testing market is studied across various key countries of regions such as, North America, Europe, Asia Pacific and Rest of the World.

The clinical disease diagnosis application segment is expected to dominate the rapid microbiology testing market during the forecast period

The clinical disease diagnosis application segment is expected to dominate the rapid microbiology testing market during the forecast period, due to the increasing use of rapid microbiology testing for the diagnosis of infectious diseases in humans; rising emphasis on effective and early disease diagnosis across major markets; and the introduction of advanced, accurate, and rapid methods for faster clinical diagnosis.

The growth-based rapid microbiology testing segment is anticipated dominate the market in 2019

Among the various methods employed in the rapid microbiology testing, the growth-based rapid microbiology testing segment is anticipated dominate the market in 2019, due to factors such as the ease of processing (this method uses conventional liquid or agar media), the limited requirement of skilled professionals, and supportive government regulations.

In 2019, diagnostic laboratories & hospitals accounted for the major market share

In 2019, diagnostic laboratories & hospitals accounted for the major market share in terms of revenue, due to flooding demand from critically ill patients and high occurrence of infectious disease and increasing geriatric populace.

North America dominated Rapid Microbiology Testing market in 2019 

The North America accounted for the largest market share in 2019 in terms of revenue followed by Europe. Rising prevalence of various diseases among the population, refined healthcare infrastructure, and rising need for advanced diagnostic testing are the key reasons accounted for the market growth in North America.

Key Players: 

The key competitors of this market include bioMérieux SA (France). Abbott Laboratories Inc. (US), Danaher Corporation (US), and Becton, Dickinson and Company (US), Bruker Corporation (US), Charles River Laboratories International, Inc. (US), Don Whitley Scientific Limited (UK), Merck KGaA (Germany), Neogen (US), Quidel Corporation (US), Rapid Micro Biosystems, Inc. (US), Sartorius Group (Germany), Thermo Fisher Scientific (US), TSI Inc. (US), and Vivione Biosciences, LLC (US).

Browse for more details: https://www.axiommrc.com/product/10147-rapid-microbiology-testing-market-report 

Contact Us:

Ganesh Sai

United States

3 Germay Dr.Ste 4 - 4666

Wilmington DE 19804

U.S.:- + 1 (845) 875-9786

U.K.:- + 44 (0) 20 3286 9707

Email: sales@axiommrc.com